173 related articles for article (PubMed ID: 9657629)
21. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
[TBL] [Abstract][Full Text] [Related]
23. Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47
Boonprom P; Boonla O; Chayaburakul K; Welbat JU; Pannangpetch P; Kukongviriyapan U; Kukongviriyapan V; Pakdeechote P; Prachaney P
Ann Anat; 2017 Jul; 212():27-36. PubMed ID: 28455132
[TBL] [Abstract][Full Text] [Related]
24. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis.
Moreno H; Piovesan Nathan L; Pereira Costa SK; Metze K; Antunes E; Zatz R; De Nucci G
Eur J Pharmacol; 1995 Dec; 287(1):93-6. PubMed ID: 8666033
[TBL] [Abstract][Full Text] [Related]
25. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
Shigihara T; Sato A; Hayashi K; Saruta T
Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at established stage of hypertension.
Yokota S; Naito Y; Yoshida H; Ohara N; Adachi T; Narita H
Jpn J Pharmacol; 1998 May; 77(1):79-87. PubMed ID: 9639063
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
[TBL] [Abstract][Full Text] [Related]
28. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
Morton JJ; Beattie EC; Speirs A; Gulliver F
J Hypertens; 1993 Oct; 11(10):1083-8. PubMed ID: 8258672
[TBL] [Abstract][Full Text] [Related]
29. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
30. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
32. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
33. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
Kobayashi N; Hara K; Higashi T; Matsuoka H
Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
35. Effect of Ca2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat.
de Oliveira CF; Nathan LP; Metze K; Moreno H; de Luca IM; Sucupira M; Zatz R; Zappellini A; Antunes E; de Nucci G
Eur J Pharmacol; 1999 Jun; 373(2-3):195-200. PubMed ID: 10414439
[TBL] [Abstract][Full Text] [Related]
36. Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
Katoh M; Egashira K; Kataoka C; Usui M; Koyanagi M; Kitamoto S; Ohmachi Y; Takeshita A; Narita H
Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2306-12. PubMed ID: 11299235
[TBL] [Abstract][Full Text] [Related]
37. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats.
Kashiwagi M; Shinozaki M; Hirakata H; Tamaki K; Hirano T; Tokumoto M; Goto H; Okuda S; Fujishima M
J Am Soc Nephrol; 2000 Apr; 11(4):616-624. PubMed ID: 10752520
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
Cachofeiro V; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Lahera V
Hypertension; 1995 Aug; 26(2):236-43. PubMed ID: 7635531
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
40. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
